Hong Kong Customs seizes drugs worth over $431 million in joint anti-narcotics operation
Hong Kong Customs conducted a large-scale anti-narcotics operation at Hong Kong International Airport from October 1 to December 31 last year to combat drug trafficking activities by aviation channels. During the operation, Hong Kong Customs, Mainland and overseas law enforcement agencies detected a total of 183 drug cases, seizing around 1.4 tons of suspected drugs including ketamine, cannabis, methamphetamine, cocaine, MDMA and heroin, with an estimated market value of over $431 million. Sixty-two persons suspected to be connected with the cases were arrested.
During the operation, Hong Kong Customs collaborated with 16 Mainland and overseas law enforcement agencies, maintained close and real-time exchange of intelligence and conducted joint assessments to effectively track and intercept drug trafficking activities. The Anti-Smuggling Bureau of Mainland Customs, Macao Judiciary Police, German Customs, French Customs, New Zealand Customs Service and Thai Customs Department also successfully detected drug trafficking cases in their respective regions.
Customs has been closely monitoring the trends of drug markets and smuggling channels, and has strived to intercept drug trafficking activities at import, transit and export levels based on risk assessment and intelligence analysis. Customs will continue to make necessary adjustments in strategy and deployments in accordance with changes in the drug trafficking trends, and deepen co-operation with overseas enforcement agencies to fight against cross-boundary narcotics trafficking activities.
Customs reminds members of the public to stay alert and not to participate in drug trafficking activities for monetary return. They must not accept hiring or delegation from another party to carry controlled items into and out of Hong Kong. They are also reminded not to carry unknown items for other people.
Under the Dangerous Drugs Ordinance, trafficking in a dangerous drug is a serious offence. The maximum penalty upon conviction is a fine of $5 million and life imprisonment.
Members of the public may report any suspected drug trafficking activities to Customs' 24-hour hotline 182 8080 or its dedicated crime-reporting email account (crimereport@customs.gov.hk) or online form (eform.cefs.gov.hk/form/ced002).
Hong Kong Customs seizes drugs worth over $431 million in joint anti-narcotics operation Source: HKSAR Government Press Releases
Hong Kong Customs seizes drugs worth over $431 million in joint anti-narcotics operation Source: HKSAR Government Press Releases
Hong Kong Customs seizes drugs worth over $431 million in joint anti-narcotics operation Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia
The Hong Kong Economic and Trade Office in New York (New York ETO) hosted a business forum and spring reception on March 12 (Philadelphia time) in Philadelphia, one of the most significant life science clusters in the United States, to promote Hong Kong's expanding role as a global hub for health and life sciences innovation and to explore opportunities for cross-border collaboration. Over 130 business leaders, investors, and innovators from across Greater Philadelphia gathered to learn more about Hong Kong's role as an international life and health science hub.
As part of the Economic and Trade Express initiative, the business forum was co-organised by the New York ETO, Invest Hong Kong, and the Hong Kong Trade Development Council (HKTDC), strengthening efforts in trade and investment promotion, and reinforcing Hong Kong's role as a "super connector" and "super value-adder".
In her welcome remarks, the Director of the New York ETO, Ms Maisie Ho, highlighted Hong Kong's remarkable progress in life sciences and healthcare, emphasising the latest measures to propel Hong Kong's life sciences and health technology ecosystem through a multipronged approach.
She elaborated on Hong Kong's integrated development plan, including reforming the evaluation regime for drugs and medical devices, promoting the use of real-world data to facilitate clinical research, setting up dedicated institutes and academies for research and clinical trials at the Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone in the Northern Metropolis, as well as dedicated efforts in attracting strategic enterprises, with a view to further strengthening Hong Kong's position as a leading health and innovation node.
Ms Ho added that Hong Kong's well-established financial ecosystem continues to play a pivotal role in supporting this growth. "Hong Kong ranks as the world's second-largest biotech fundraising hub, supporting a diverse range of innovative companies," she said.
The business forum featured two keynote presentations connecting life sciences and health innovation between Philadelphia and Hong Kong. In her keynote presentation, the Head of Business and Talent Attraction/Investment Promotion of the Invest Hong Kong in New York, Ms Yi Xie, highlighted Hong Kong as a launchpad for life sciences, showcasing its well- developed research and development infrastructure, robust intellectual property protection, and strategic gateway to the Guangdong–Hong Kong–Macao Greater Bay Area and Asia-Pacific markets. Meanwhile, the Director (New York & Midwest) of the HKTDC, Mr Curtis Louie, shared the range of support the HKTDC provides to Philadelphia companies, including matchmaking services for companies, and encouraged delegation participation in the upcoming Asia Summit on Global Health.
The presentations were then followed by a panel discussion moderated by the President and Chief Executive Officer of the Science History Institute, Dr David Cole, featuring the Founder and Chief Executive Officer of the ConSynance Therapeutics, Dr Liu Shuang; the Head of Global Business Development of the Jecho Laboratories, Dr Sarah Johnson; and the Director, Deal Advisory, US-China Corridor of KPMG, Mr Jon Hung. The speakers discussed collaboration, fundraising, clinical development, and market expansion in Asia.
On the same evening, Ms Ho hosted a spring reception for guests from the city's political, business, financial, and academic communities.
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
New York ETO promotes Hong Kong's life sciences and health innovation in Philadelphia Source: HKSAR Government Press Releases
